Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Debolina Pramanik, Yanwen Chen, Shramana Sarkar, Aaron Gerds, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3790.

https://doi.org/10.1182/blood-2025-3790

Published: 2025

Journal Articles

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Debolina Pramanik, Yanwen Chen, Shramana Sarkar, Ishan Gupta, Aaron Gerds, Hetty Carraway, Abhay Singh, Anjali Advani, Moaath Mustafa Ali, John Molina, Sophia Balderman, Akriti Jain, Faiz Anwer, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3772.

https://doi.org/10.1182/blood-2025-3772

Published: 2025

Journal Articles

Risk of therapy-related acute lymphoblastic leukemia (t-ALL) in cancer patients secondary to either chemotherapy, radiation, or both: A retrospective cohort study from 1975-2021 using SEER registry

Krishna Desai, Yanwen Chen, Hetty Carraway, Aaron Gerds, Akriti Jain, Abhay Singh, Anjali Advani, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 3331.

https://doi.org/10.1182/blood-2025-3331

Published: 2025

Journal Articles

The Epidemiology of Cardiovascular Disease in African American Patients with Myeloid Neoplasms: A SEER Data Analysis

Sindhusha Veeraballi, Yanwen Chen, Hetty E. Carraway, Aaron T. Gerds, Moaath K. Mustafa Ali, Arooj Ahmed, Anjali S. Advani, John C Molina, Sophia Balderman, Jaroslaw P. Maciejewski, Sudipto Mukherjee, Abhay Singh

Blood (2023) 142 (Supplement 1): 5181.

https://doi.org/10.1182/blood-2023-189294

Published: 2023

Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi

Blood (2023) 142 (Supplement 1): 3087.

https://doi.org/10.1182/blood-2023-173943

Published: 2023

Journal Articles

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

Julia H. Joo, Yanwen Chen, Aaron T. Gerds, Anjali Advani, Sophia R. Balderman, Hetty E. Carraway, Abhay Singh Singh, Sudipto Mukherjee

Blood (2022) 140 (Supplement 1): 687–689.

https://doi.org/10.1182/blood-2022-163565

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Risk of therapy-related acute lymphoblastic leukemia (t-ALL) in cancer patients secondary to either chemotherapy, radiation, or both: A retrospective cohort study from 1975-2021 using SEER registry

The Epidemiology of Cardiovascular Disease in African American Patients with Myeloid Neoplasms: A SEER Data Analysis

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

Email alerts

ASH Publications

American Society of Hematology

Update search

Risk of second primary malignancies and leukemic transformation in patients with Philadelphia chromosome-negative myeloproliferative neoplasms: A population-level US retrospective cohort study

Survival and risk of second primary malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A retrospective US population-level analysis

Risk of therapy-related acute lymphoblastic leukemia (t-ALL) in cancer patients secondary to either chemotherapy, radiation, or both: A retrospective cohort study from 1975-2021 using SEER registry

The Epidemiology of Cardiovascular Disease in African American Patients with Myeloid Neoplasms: A SEER Data Analysis

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Risk of Therapy-Related Acute Myeloid Leukemia (t-AML) in Cancer Patients Treated with Chemotherapy with or without Radiotherapy: A National Population-Based Cohort Study Using SEER Registry

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only